Kairos Pharma KAPA
NYSE KAPA
$0.57 +0.03 (+4.78%)
As of: Oct 23, 2026 · 3:39 PM EDT

Kairos Pharma (KAPA) Profit After Tax (2023 - 2025)

Updated

Kairos Pharma's Profit After Tax was -$5.45 million in FY2025, compared with -$2.38 million in FY2024.

Analysis

Kairos Pharma (KAPA) Profit After Tax (2023 - 2025) Analysis & Trends

  • Per Business Quant data, Profit After Tax in earlier years was -$2.38 million in FY2024 and -$1.76 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Eli Lilly 1,131.95 Bn 1,100.53 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 635.80 Bn 555.66 Bn 17.30 Bn 210.00 Mn
3 AbbVie 506.62 Bn 479.73 Bn 12.70 Bn 3.62 Bn
4 Merck 358.64 Bn 313.02 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 292.18 Bn 256.17 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 265.70 Bn 239.39 Bn 12.86 Bn 2.51 Bn
7 Amgen 237.74 Bn 193.14 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 195.25 Bn 169.45 Bn 6.22 Bn -10.50 Bn
9 Pfizer 171.25 Bn 117.90 Bn 10.94 Bn -246.00 Mn
10 Kairos Pharma 10.50 Mn -1.91 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -1.42 Mn
Mar 31, 2025 -1.26 Mn
Dec 31, 2024 -1.45 Mn
Sep 30, 2024 -395,000.00
Jun 30, 2024 -234,000.00
Mar 31, 2024 -303,000.00
Dec 31, 2023 -1.09 Mn
Sep 30, 2023 -302,000.00
API Access

Kairos Pharma Profit After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=KAPA&period=max&api_key=YOUR_API_KEY